Leerink Partners Downgrades Veracyte to Market Perform, Lowers Price Target to $35
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsDowngradesPrice Target
Leerink Partners analyst Puneet Souda downgrades Veracyte (NASDAQ:VCYT) from Outperform to Market Perform and lowers the price target from $55 to $35.
Leerink Partners analyst Puneet Souda downgrades Veracyte (NASDAQ:VCYT) from Outperform to Market Perform and lowers the price target from $55 to $35.
